Deutche Bank came out last night with a different view and ended up stating that the 24 month group is approaching 1:1000. That's still not great per se.
These data points have to be plotted out just like any other scientific measure to really see what the results will be.
The only real answer is that we don't know what causes PML and if Ty's effect treatment is cumlative or not. Only time will tell.
It has only been because of Ty's side effects that Emerck has gone ahead with the EU oral drug filing this week.
I'm having trouble understanding...how have the new cases went from 1 in 2400, to 1 in 1200, to 1 in 600?
Only 11 reports of this infection are present in over 43,000 people on the drug. This translates to about 1 in 4000, which are also the stats I read in an article. I don't trust the article as much as the math in front of me, so am I missing something about these numbers? By your math, this means that out of the 3,000+ people that were added to the drug in June, 5 of them should end up with this infection. Something seems wrong with that math...please correct me if I'm wrong.
something is going on...good or bad. Ask price is now down to 7.36. I hope that it's being driven down so someone can pick up some cheap shares before a major jump...otherwise I'm not looking forward to Monday! Let's hope...IMO